Cardiac sympathetic dysfunction correlates with abnormal myocardial contractile reserve in dilated cardiomyopathy patients.

[1]  M. Quiñones.  Assessment of diastolic function. , 2005, Progress in cardiovascular diseases.

[2]  M. Kitakaze,et al.  Changes in myocardial gene expression associated with β-blocker therapy in patients with chronic heart failure , 2003 .

[3]  P. Merlet,et al.  Uptake-1 carrier downregulates in parallel with the beta-adrenergic receptor desensitization in rat hearts chronically exposed to high levels of circulating norepinephrine: implications for cardiac neuroimaging in human cardiomyopathies. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  H. Izawa,et al.  Prognostic value of mechanical efficiency in ambulatory patients with idiopathic dilated cardiomyopathy in sinus rhythm. , 2002, Journal of the American College of Cardiology.

[5]  H. Izawa,et al.  Reduced Myocardial Sarcoplasmic Reticulum Ca2+-ATPase mRNA Expression and Biphasic Force-Frequency Relations in Patients With Hypertrophic Cardiomyopathy , 2001, Circulation.

[6]  D. Bers,et al.  Ca2+ handling and sarcoplasmic reticulum Ca2+ content in isolated failing and nonfailing human myocardium. , 1999, Circulation research.

[7]  Fach,et al.  Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.

[8]  A. Matsumori,et al.  Cellular and molecular remodeling in a heart failure model treated with the β-blocker carteolol. , 1999, American journal of physiology. Heart and circulatory physiology.

[9]  H. Izawa,et al.  Impaired force-frequency relations in patients with hypertensive left ventricular hypertrophy. A possible physiological marker of the transition from physiological to pathological hypertrophy. , 1999, Circulation.

[10]  T. Suzuki,et al.  Cardiac sympathetic activity estimated by 123I-MIBG myocardial imaging in patients with dilated cardiomyopathy after beta-blocker or angiotensin-converting enzyme inhibitor therapy. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  CIBIS-II Investigators and Committees.  The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.

[12]  K. Okamoto,et al.  Quantitative scintigraphic analysis of 123I-MIBG by polar map in patients with dilated cardiomyopathy. , 1997, Nuclear medicine communications.

[13]  T. Suzuki,et al.  Myocardial contractile reserve as prognostic determinant in patients with idiopathic dilated cardiomyopathy without overt heart failure. , 1997, Chest.

[14]  R. Walsh,et al.  Effects of thyroid hormone on left ventricular performance and regulation of contractile and Ca(2+)-cycling proteins in the baboon. Implications for the force-frequency and relaxation-frequency relationships. , 1996, Circulation research.

[15]  A. Quyyumi,et al.  Cardiac sympathetic nerve function in congestive heart failure. , 1996, Circulation.

[16]  B Maisch,et al.  Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. , 1996, Circulation.

[17]  S. Tazawa,et al.  Assessment of adrenergic neuron function altered with progression of heart failure. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  G. Jennings,et al.  Adverse consequences of high sympathetic nervous activity in the failing human heart. , 1995, Journal of the American College of Cardiology.

[19]  H. Drexler,et al.  Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium. , 1994, Circulation research.

[20]  G. Hasenfuss,et al.  Influence of the force-frequency relationship on haemodynamics and left ventricular function in patients with non-failing hearts and in patients with dilated cardiomyopathy. , 1994, European heart journal.

[21]  P. Merlet,et al.  Positron emission tomography with 11C CGP-12177 to assess beta-adrenergic receptor concentration in idiopathic dilated cardiomyopathy. , 1993, Circulation.

[22]  J. McCarrey,et al.  Single-step elimination of contaminating DNA prior to reverse transcriptase PCR. , 1992, PCR methods and applications.

[23]  N. Alpert,et al.  Altered Myocardial Force‐Frequency Relation in Human Heart Failure , 1992, Circulation.

[24]  M. Inui,et al.  Molecular mechanism of regulation of Ca2+ pump ATPase by phospholamban in cardiac sarcoplasmic reticulum. Effects of synthetic phospholamban peptides on Ca2+ pump ATPase. , 1992, The Journal of biological chemistry.

[25]  I. Meredith,et al.  Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. , 1991, The New England journal of medicine.

[26]  William F. DeGrado,et al.  How calmodulin binds its targets: sequence independent recognition of amphiphilic α-helices , 1990 .

[27]  N. Reichek,et al.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[28]  M. Feldman,et al.  Depression of systolic and diastolic myocardial reserve during atrial pacing tachycardia in patients with dilated cardiomyopathy. , 1988, The Journal of clinical investigation.

[29]  J. Sisson,et al.  Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[30]  W Grossman,et al.  Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. , 1987, Circulation research.

[31]  G. Meissner,et al.  Ryanodine activation and inhibition of the Ca2+ release channel of sarcoplasmic reticulum. , 1986, The Journal of biological chemistry.

[32]  P. Korner,et al.  Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. , 1986, Circulation.

[33]  I. Mirsky.  Assessment of diastolic function: suggested methods and future considerations. , 1984, Circulation.

[34]  H Sandler,et al.  The use of single plane angiocardiograms for the calculation of left ventricular volume in man. , 1968, American heart journal.

[35]  E. Sonnenblick,et al.  Norepinephrine Stores and Contractile Force of Papillary Muscle from the Failing Human Heart , 1966, Circulation.

[36]  W. DeGrado,et al.  How calmodulin binds its targets: sequence independent recognition of amphiphilic alpha-helices. , 1990, Trends in biochemical sciences.

[37]  M. Nakajo,et al.  Iodine-131 metaiodobenzylguanidine intra- and extravesicular accumulation in the rat heart. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.